Personal profile

Brief presentation

Experienced leader with many years of management in the cutting-edge fields of cell therapy and gene editing (viral- and non-viral). Passionate about driving innovation and transforming healthcare through groundbreaking technologies (TIL-therapy, CAR-T therapy). Proven track record of guiding cross-functional teams, fostering collaboration, and successfully navigating complex regulatory landscapes. Committed to advancing the frontiers of science and delivering life-changing treatments to patients in need.

Main research areas

Research focus is in the area of molecular and cellular tumor immunology which includes both basic research and development of novel molecular immunotherapeutic strategies for treatment of cancer. 

Current research

Develop isolation and expansion methods for tumor-infiltrating lymphocyte (TIL) and to produce large-scale GMP-grade TIL products for adoptive cell therapy (ACT) clinical trials for melanoma and other solid tumors.
Development and exploitation of novel costimulatory chimeric antigen receptors (CARs) to be used ACT studies.



Dive into the research topics where Özcan Met is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or